Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  Biotech  >  Current Article

Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

By   /   Friday, August 28th, 2020  /   Comments Off on Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

    Print       Email
Camarillo startup ImmPACT Bio is joining the pursuit for T-cell immunotherapies with $18 million in its pocket. The company is setting up shop in a Southern California hotbed for the avenue of research, which seeks to treat solid tumors using patients’ own immune cells. That includes efforts from regional heavyweight Amgen and Thousand Oaks-based Atara…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: After a decade ruled by tech, value stocks could make a comeback

Read More →